Showing 1 - 10 of 3,165
Persistent link: https://www.econbiz.de/10013407493
MRNA technology has proved in the context of the COVID-19 pandemic its breakthrough value as a basis for vaccines. There has been rapid development of highly safe, effective and robust mRNA vaccines, and these can be delivered at large scale. Yet the technology is the result of a long process of...
Persistent link: https://www.econbiz.de/10013184655
Persistent link: https://www.econbiz.de/10013545964
Persistent link: https://www.econbiz.de/10014304328
Persistent link: https://www.econbiz.de/10012244582
Persistent link: https://www.econbiz.de/10012503266
This paper examines the effects of globalisation on the pace of governments implementing international travel restrictions during the recent coronavirus pandemic. We find that more globalised countries experienced a longer delay in implementing international travel restriction policies with...
Persistent link: https://www.econbiz.de/10012242056
Persistent link: https://www.econbiz.de/10012504447
optimal. When eradication is feasible, the optimal program requires either a low vaccination rate or eradication. A high … vaccination rate is never optimal. Under special conditions, the results are especially stark: the optimal policy is either not to …
Persistent link: https://www.econbiz.de/10011601157
, qualitative, and quantitative dynamic norms, on actual vaccination rates. Contrary to our hypothesis, dynamic norms alone fail to … influence second-dose HPV vaccination rates for these trendsetters. However, the study reveals a 5.22 percent increase …
Persistent link: https://www.econbiz.de/10014540586